European Commission: Commission proposes to purchase up to 300 million additional doses of BioNTech-Pfizer vaccine

The European Commission today proposed to the EU Member States to purchase an additional 200 million doses of the COVID-19 vaccine produced by BioNTech and Pfizer, with the option to acquire another 100 million doses.

This would enable the EU to purchase up to 600 million doses of this vaccine, which is already being used across the EU.

The additional doses will be delivered starting in the second quarter of 2021.

The EU has acquired a broad portfolio of vaccines with different technologies. It has secured up to 2.3 billion doses from the most promising vaccine candidates for Europe and its neighbourhood.

In addition to the BioNTech-Pfizer vaccine, a second vaccine, produced by Moderna, was authorised on 6 January 2021. Other vaccines are expected to be approved soon.

This vaccine portfolio would enable the EU not only to cover the needs of its whole population, but also to supply vaccines to neighbouring countries.

Source


Tags assigned to this article:
coronaviruscovid-19

You may have an interest in also reading…

World Bank Blogs: Scaling up the COVID-19 crisis response now will avoid higher costs later

After a decade of uninterrupted growth, the global economy came to a sudden halt because of the COVID-19 pandemic.  The question

UN News: WHO reviewing impact of US funding withdrawal amid COVID-19 pandemic

The head of the World Health Organization (WHO) on Wednesday upheld the importance of international solidarity in tackling the COVID-19

WHO urges mask use in confined public areas, where coronavirus still spreads

Governments in areas with widespread COVID-19 transmission should encourage the use of non-medical masks on public transport, in shops and